John R. Peterson, Ph.D.,President & Founder of Thesis Chemistry, an alliance partner of BioChemInsights. Together, Thesis Chemistry and BioChemInsights are "One Source for CMC Management" to provide the chemistry necessary for drug development from concept to commercialization.
Throughout his career, Dr. Peterson has been technically focused on organic chemical synthesis. He has over 25 years of commercial experience in drug development, fine chemicals and chiral molecules for pharmaceuticals, chemical process development and optimization, chemical manufacturing of key pharmaceutical intermediates and APIs. Dr. Peterson has broad business and technical expertise in the development of innovative and proprietary process chemistry for regulatory starting materials and key intermediates for cGMP manufacturing processes. Throughout his career, he has held management positions with Ricerca Biosciences, Oxford Asymmetry, MDS Panlabs, University of Washington and the University of Mississippi.
Dr. Peterson received his B.S. in Chemistry from the University of Minnesota in 1979 and his Ph.D. in chemistry from the University of Minnesota in 1984.He was a National Institutes of Health Post-doctoral Fellow at the Ohio State University from 1984-86.In 1993, he completed the Executive management Program at the University of Washington.
https://biocheminsights.com
Our products and services are leading in industrial and consumer markets with rapid growth of drugs, chemicals and fuels based on renewable resources and sustainable technology. As a high -tech R & D company, development, licenses and commercialization products and technologies for biological processing.With the breakthrough of chemical industry technology, catalyst technology, and large -scale equipment manufacturing technology, the Chinese chemical industry has completed any chemicals produced by crude oil as raw materials.
